摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4-Methoxy-phenyl)-4-methyl-1H-benzoimidazole

中文名称
——
中文别名
——
英文名称
2-(4-Methoxy-phenyl)-4-methyl-1H-benzoimidazole
英文别名
2-(4-methoxyphenyl)-4-methyl-1H-benzimidazole
2-(4-Methoxy-phenyl)-4-methyl-1H-benzoimidazole化学式
CAS
——
化学式
C15H14N2O
mdl
MFCD11732394
分子量
238.289
InChiKey
HYXHMHWPHUMEJM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.133
  • 拓扑面积:
    37.9
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    4-甲氧基苯甲醛2,3-二氨基甲苯 在 sodium meta bi sulfate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 130.0 ℃ 、101.33 kPa 条件下, 生成 2-(4-Methoxy-phenyl)-4-methyl-1H-benzoimidazole
    参考文献:
    名称:
    Synthesis, α-glucosidase inhibitory, cytotoxicity and docking studies of 2-aryl-7-methylbenzimidazoles
    摘要:
    Benzimidazole analogs 1-27 were synthesized, characterized by EI-MS and H-1 NMR and their alpha-glucosidase inhibitory activities were found out experimentally. Compound 25, 19, 10 and 20 have best inhibitory activities with IC50 values 5.30 +/- 0.10, 16.10 +/- 0.10, 25.36 +/- 0.14 and 29.75 +/- 0.19 respectively against alpha-glucosidase. Compound 6 and 12 has no inhibitory activity against alpha-glucosidase enzyme among the series. Further studies showed that the compounds are not showing any cytotoxicity effect. The docking studies of the compounds as well as the experimental activities of the compounds correlated well. From the molecular docking studies, it was observed that the top ranked conformation of all the compounds fit well in the active site of the homology model of alpha-glucosidase. (C) 2016 Elsevier Inc. All rights reserved.
    DOI:
    10.1016/j.bioorg.2016.02.004
点击查看最新优质反应信息

文献信息

  • Farnesoid X Receptor Agonists
    申请人:Deaton David Norman
    公开号:US20100249179A1
    公开(公告)日:2010-09-30
    The present invention provides novel isoxazole compounds, pharmaceutical compositions, therapeutic uses and processes for preparing the same.
    本发明提供了新型异噁唑化合物、制药组合物、治疗用途和制备方法。
  • [EN] COMPOSITION FOR THE VAPOR PHASE DEHYDROHALOGENATION OF 1,1,2-TRIHALOETHANE TO 1,1-DIHALOETHYLENE AND METHODS FOR PREPARING AND USING SUCH COMPOSITIONS<br/>[FR] PREPARATION POUR LA DESHYDROHALOGENATION EN PHASE VAPEUR DE 1,1,2-TRIHALOGENOETHANE EN 1,1-DIHALOGENOETHYLENE ET PROCEDES D'ELABORATION ET D'EMPLOI DE TELLES PREPARATIONS
    申请人:PPG IND OHIO INC
    公开号:WO2006132625A1
    公开(公告)日:2006-12-14
    [EN] Described are compositions adapted to catalyze the vapor phase dehydrohalogenation of 1,1,2-trihaloethane to 1,1-dihaloethylene, e.g., 1,1,2-trichloroethane to vinylidene chloride. These materials include activated carbon and at least one benzimidazole-containing material defined herein as including benzimidazole, a derivative thereof, a salt thereof or mixtures thereof. Also described are methods for producing and using these catalytic compositions.
    [FR] La présente invention concerne des préparations adaptées à la catalyse de la déshydrohalogénation en phase vapeur de 1,1,2-trihalogénoéthane en 1,1-dihalogénoéthylène, par exemple de 1,1,2-trichloroéthane en chlorure de vinylidène. Ces matériaux incluent du charbon actif et au moins un matériau contenant du benzimidazole, défini dans la présente invention comme incluant le benzimidazole, un dérivé de benzimidazole, un sel de benzimidazole ou des mélanges de ces substances. La présente invention concerne également des procédés d'élaboration et d'emploi de telles préparations catalytiques.
  • Synthesis, α-glucosidase inhibitory, cytotoxicity and docking studies of 2-aryl-7-methylbenzimidazoles
    作者:Muhammad Taha、Nor Hadiani Ismail、Syahrul Imran、Muhammad Helmi Mohamad、Abdul Wadood、Fazal Rahim、Syed Muhammad Saad、Ashfaq ur Rehman、Khalid Mohammed Khan
    DOI:10.1016/j.bioorg.2016.02.004
    日期:2016.4
    Benzimidazole analogs 1-27 were synthesized, characterized by EI-MS and H-1 NMR and their alpha-glucosidase inhibitory activities were found out experimentally. Compound 25, 19, 10 and 20 have best inhibitory activities with IC50 values 5.30 +/- 0.10, 16.10 +/- 0.10, 25.36 +/- 0.14 and 29.75 +/- 0.19 respectively against alpha-glucosidase. Compound 6 and 12 has no inhibitory activity against alpha-glucosidase enzyme among the series. Further studies showed that the compounds are not showing any cytotoxicity effect. The docking studies of the compounds as well as the experimental activities of the compounds correlated well. From the molecular docking studies, it was observed that the top ranked conformation of all the compounds fit well in the active site of the homology model of alpha-glucosidase. (C) 2016 Elsevier Inc. All rights reserved.
查看更多